CN1471519A - 氨基烯基苯甲酰基-苯并呋喃或苯并噻吩,它们的制备方法与含有它们的组合物 - Google Patents

氨基烯基苯甲酰基-苯并呋喃或苯并噻吩,它们的制备方法与含有它们的组合物 Download PDF

Info

Publication number
CN1471519A
CN1471519A CNA018177654A CN01817765A CN1471519A CN 1471519 A CN1471519 A CN 1471519A CN A018177654 A CNA018177654 A CN A018177654A CN 01817765 A CN01817765 A CN 01817765A CN 1471519 A CN1471519 A CN 1471519A
Authority
CN
China
Prior art keywords
formula
compound
group
cumarone
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA018177654A
Other languages
English (en)
Chinese (zh)
Inventor
J��L����ɭ˹
J·L·阿森斯
C·伯恩哈特
��ڶ�-����������
F·卡巴内尔-豪德里库尔特
��ɣ��˹��������
V·多斯
���ٶ���԰�������޹�˾
�桑托斯
P·戈蒂尔
D·尼萨托
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of CN1471519A publication Critical patent/CN1471519A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CNA018177654A 2000-08-23 2001-08-23 氨基烯基苯甲酰基-苯并呋喃或苯并噻吩,它们的制备方法与含有它们的组合物 Pending CN1471519A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR00/10835 2000-08-23
FR0010835A FR2813307B1 (fr) 2000-08-23 2000-08-23 Aminoalkenylbenzoyl-benzofurannes ou benzothiophenes, leur procede de preparation et les compositions les contenant

Publications (1)

Publication Number Publication Date
CN1471519A true CN1471519A (zh) 2004-01-28

Family

ID=8853675

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA018177654A Pending CN1471519A (zh) 2000-08-23 2001-08-23 氨基烯基苯甲酰基-苯并呋喃或苯并噻吩,它们的制备方法与含有它们的组合物

Country Status (25)

Country Link
US (1) US6946483B2 (US06946483-20050920-C00045.png)
EP (1) EP1315708B1 (US06946483-20050920-C00045.png)
JP (1) JP4918209B2 (US06946483-20050920-C00045.png)
KR (1) KR20030023768A (US06946483-20050920-C00045.png)
CN (1) CN1471519A (US06946483-20050920-C00045.png)
AT (1) ATE273293T1 (US06946483-20050920-C00045.png)
AU (1) AU2001284154A1 (US06946483-20050920-C00045.png)
BG (1) BG107553A (US06946483-20050920-C00045.png)
BR (1) BR0113350A (US06946483-20050920-C00045.png)
CA (1) CA2415846A1 (US06946483-20050920-C00045.png)
CZ (1) CZ2003520A3 (US06946483-20050920-C00045.png)
DE (1) DE60104866T2 (US06946483-20050920-C00045.png)
EA (1) EA200300063A1 (US06946483-20050920-C00045.png)
FR (1) FR2813307B1 (US06946483-20050920-C00045.png)
HU (1) HUP0302892A3 (US06946483-20050920-C00045.png)
IL (1) IL153637A0 (US06946483-20050920-C00045.png)
IS (1) IS6676A (US06946483-20050920-C00045.png)
MA (1) MA26944A1 (US06946483-20050920-C00045.png)
MX (1) MXPA03001592A (US06946483-20050920-C00045.png)
NO (1) NO20030801L (US06946483-20050920-C00045.png)
OA (1) OA12358A (US06946483-20050920-C00045.png)
PL (1) PL362123A1 (US06946483-20050920-C00045.png)
SK (1) SK2112003A3 (US06946483-20050920-C00045.png)
WO (1) WO2002016338A1 (US06946483-20050920-C00045.png)
ZA (1) ZA200300746B (US06946483-20050920-C00045.png)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107827849A (zh) * 2017-11-14 2018-03-23 沈阳药科大学 6‑[2‑羟基‑3‑(烷胺基)丙氧基]苯并呋喃类化合物及其应用
CN107857748A (zh) * 2017-11-14 2018-03-30 沈阳药科大学 5‑[2‑羟基‑3‑(烷胺基)丙氧基]苯并呋喃类化合物及其应用
CN107935972A (zh) * 2017-11-14 2018-04-20 沈阳药科大学 5‑[2‑羟基‑3‑(异丙胺基)丙氧基]苯并呋喃类衍生物及其应用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG173014A1 (en) 2009-01-16 2011-08-29 Exelixis Inc Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl] oxy}phenyl)-n' - (4 -fluorophenyl) cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
AU2011202542A1 (en) 2010-07-14 2012-02-02 Indian Institute Of Science Benzothiophene carboxamide compounds, composition and applications thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248401A (en) * 1966-04-26 Diethylaminoe hoxybenzoyl benzofurans
US4831054A (en) * 1988-04-18 1989-05-16 Taro Pharmaceuticals, Ltd. 2-Alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia
AT391316B (de) * 1988-09-15 1990-09-25 Ebewe Arzneimittel Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2665444B1 (fr) * 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
US5364880A (en) * 1993-06-16 1994-11-15 Advanced Therapies, Inc. Compound for treatment of cardiac arrhythmia, synthesis, and methods of use
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5622974A (en) * 1995-03-10 1997-04-22 Eli Lilly And Company α-substituted-3-benzyl-benzofurans
US5523309A (en) * 1995-03-10 1996-06-04 Eli Lilly And Company Benzofuran pharmaceutical compounds
CA2220991A1 (en) * 1995-06-26 1997-01-16 Eli Lilly And Company Benzothiophene compounds
US5827876A (en) * 1996-04-09 1998-10-27 American Home Products Corporation Inhibition of bone loss by 3-(4-acrylamidobenzoyl) benzo b!-thiophenes
AU3171099A (en) * 1998-04-17 1999-11-08 Senga Pharmaceutical Laboratory Inc. 1-heteroindene derivatives and medicinal composition containing the same

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107827849A (zh) * 2017-11-14 2018-03-23 沈阳药科大学 6‑[2‑羟基‑3‑(烷胺基)丙氧基]苯并呋喃类化合物及其应用
CN107857748A (zh) * 2017-11-14 2018-03-30 沈阳药科大学 5‑[2‑羟基‑3‑(烷胺基)丙氧基]苯并呋喃类化合物及其应用
CN107935972A (zh) * 2017-11-14 2018-04-20 沈阳药科大学 5‑[2‑羟基‑3‑(异丙胺基)丙氧基]苯并呋喃类衍生物及其应用
CN107857748B (zh) * 2017-11-14 2020-06-02 沈阳药科大学 5-[2-羟基-3-(烷胺基)丙氧基]苯并呋喃类化合物及其应用

Also Published As

Publication number Publication date
HUP0302892A2 (hu) 2003-12-29
EP1315708B1 (fr) 2004-08-11
US6946483B2 (en) 2005-09-20
DE60104866D1 (de) 2004-09-16
ATE273293T1 (de) 2004-08-15
CZ2003520A3 (cs) 2003-05-14
ZA200300746B (en) 2004-02-10
MA26944A1 (fr) 2004-12-20
EP1315708A1 (fr) 2003-06-04
SK2112003A3 (en) 2003-08-05
US20030187060A1 (en) 2003-10-02
WO2002016338A1 (fr) 2002-02-28
WO2002016338A8 (fr) 2002-05-10
AU2001284154A1 (en) 2002-03-04
EA200300063A1 (ru) 2003-08-28
HUP0302892A3 (en) 2005-02-28
NO20030801D0 (no) 2003-02-20
IS6676A (is) 2003-01-13
BG107553A (en) 2004-01-30
JP2004506726A (ja) 2004-03-04
BR0113350A (pt) 2003-07-08
IL153637A0 (en) 2003-07-06
KR20030023768A (ko) 2003-03-19
OA12358A (fr) 2006-05-16
MXPA03001592A (es) 2003-09-10
NO20030801L (no) 2003-04-23
CA2415846A1 (fr) 2002-02-28
PL362123A1 (en) 2004-10-18
DE60104866T2 (de) 2005-10-20
FR2813307B1 (fr) 2002-11-08
FR2813307A1 (fr) 2002-03-01
JP4918209B2 (ja) 2012-04-18

Similar Documents

Publication Publication Date Title
CN1246315C (zh) 氨基烷基苯甲酰基-苯并呋喃或苯并噻吩类,它们的制备方法与含有它们的组合物
CN1242983C (zh) 苯氧基乙酸衍生物和含有该衍生物的医药组合物
CN1146540C (zh) 具有镇痛作用的新化合物及其用途
CN1036918C (zh) 苯并吡喃衍生物及含有此衍生物的k+通道活化剂
CN1589258A (zh) 新的β-苯基-α-氧取代的丙酸衍生物,它的制备方法和它们制备药学上重要的化合物的应用
CN1118595A (zh) 氨茴酸衍生物
CN1337953A (zh) 新的甲状腺受体配位体及方法ⅱ
CN101050194A (zh) 双环辛烷类衍生物、其制备方法及其在医药上的用途
CN1030252C (zh) 四氢苯并咪唑衍生物的制备方法
CN1067886A (zh) 新的脲衍生物,它们的制备方法及其药物组合物
CN1106804A (zh) 1-苯碘酰-1,3-二氢-2h-苯并咪唑-2-酮衍生物
CN1064273A (zh) 新的具有ngf生成促进活性的苯衍生物
CN1155562C (zh) 新的萘化合物、其制备方法及其药物组合物
CN1471520A (zh) 氨基烷氧基苯甲酰基-苯并呋喃类或苯并噻吩类,它们的制备方法以及含有它们的组合物
CN1047859A (zh) 苯并环烷烃衍生物及其制备方法
CN1167692C (zh) 氨基噻唑衍生物及其作为crf受体配体的用途
CN87100978A (zh) 新的二氢苯并呋喃—和苯并二氢吡喃—羧酰胺衍生物及其制备方法以及作为精神抑制药的应用
CN1244542C (zh) 具有nos抑制作用的芳香族胺衍生物
CN1034538A (zh) 作为药物有用的双脲衍生物及其制备方法
CN88102538A (zh) 新的双环化合物、其制备方法以及含这类化合物的药物组合物
CN1027536C (zh) 4,5,6,7-四氢化苯并咪唑衍生物制备方法
CN88101674A (zh) 色酮衍生物
CN1798559A (zh) 用于治疗气管疾病的喹啉-2-酮衍生物
CN1471519A (zh) 氨基烯基苯甲酰基-苯并呋喃或苯并噻吩,它们的制备方法与含有它们的组合物
CN1273463C (zh) (1-苯甲酰甲基-3-苯基-3-哌啶基乙基)哌啶衍生物,制备它们的方法以及包含它们的药物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication